Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.80 --0%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
